<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7286522\results\search\disease\results.xml">
  <result pre="Sciences : Genetics : Gene Expression: Protein Translation Bortezomib inhibits" exact="chikungunya" post="virus replication by interfering with viral protein synthesis Bortezomib"/>
  <result pre="in a dose-dependent manner. Bortezomib, which has been FDA-approved for" exact="multiple myeloma" post="and mantle cell lymphoma, was further investigated in downstream"/>
  <result pre="manner. Bortezomib, which has been FDA-approved for multiple myeloma and" exact="mantle cell lymphoma," post="was further investigated in downstream studies. The inhibitory activities"/>
  <result pre="a febrile illness accompanied by debilitating polyarthralgia, myalgia and maculopapular" exact="rash" post="[3, 4]. Chronic polyarthralgia lasting for several months to"/>
  <result pre="has been well documented for picornaviruses, including encephalomyocarditis virus and" exact="hepatitis" post="A virus, [25–27]. Given the role of the viral"/>
  <result pre="inhibitors. Bortezomib, a proteasome inhibitor approved for the treatment of" exact="multiple myeloma" post="and mantle cell lymphoma [37, 38], was selected for"/>
  <result pre="proteasome inhibitor approved for the treatment of multiple myeloma and" exact="mantle cell lymphoma" post="[37, 38], was selected for downstream experiments to investigate"/>
  <result pre="approved for the treatment of multiple myeloma and mantle cell" exact="lymphoma" post="[37, 38], was selected for downstream experiments to investigate"/>
  <result pre="manner. Bortezomib, which has been FDA-approved for the treatment of" exact="multiple myeloma" post="and mantle cell lymphoma, showed dose-dependent reductions of CHIKV"/>
  <result pre="has been FDA-approved for the treatment of multiple myeloma and" exact="mantle cell lymphoma," post="showed dose-dependent reductions of CHIKV titers in several cell"/>
  <result pre="titers in several cell lines (BHK21, HeLa and HSMM). Bortezomib-mediated" exact="suppression" post="of CHIKV titers was found to occur at an"/>
  <result pre="inhibition of viral replication [48]. As for severe fever with" exact="thrombocytopenia" post="syndrome virus (SFTSV), a phlebovirus related to RVFV, bortezomib"/>
  <result pre="induced by the viral non-structural protein (NS), thereby removing virus-mediated" exact="suppression" post="of host innate immunity [49]. Bortezomib has also been"/>
  <result pre="limitation of bortezomib is its narrow therapeutic window [61]. In" exact="cancer" post="patients, the most significant adverse effect reported is peripheral"/>
  <result pre="however, that bortezomib-induced toxicity is related to accumulated dose, with" exact="neuropathy" post="usually surfacing within the first five cycles of treatment,"/>
  <result pre="to subcutaneous has been found to significantly reduce instances of" exact="neuropathy" post="in patients, while retaining similar efficacy [37]. In addition,"/>
  <result pre="study include BHK21 baby hamster kidney cells (ATCC CCL-10), HeLa" exact="cervical cancer" post="epithelial cells (ATCC CCL-2), human skeletal muscle myoblasts (HSMM,"/>
  <result pre="include BHK21 baby hamster kidney cells (ATCC CCL-10), HeLa cervical" exact="cancer" post="epithelial cells (ATCC CCL-2), human skeletal muscle myoblasts (HSMM,"/>
  <result pre="Res. 2015;120:32–9. 10.1016/j.antiviral.2015.04.01625979669 2WahidB, AliA, RafiqueS, IdreesM. Global expansion of" exact="chikungunya" post="virus: mapping the 64-year history. Int J Infect Dis."/>
  <result pre="BreimanRF, PowersAM. Chikungunya fever: an epidemiological review of a re-emerging" exact="infectious disease." post="Clin Infect Dis. 2009;49(6):942–8. 10.1086/60549619663604 5FourieED, MorrisonJG. Rheumatoid arthritic"/>
  <result pre="Infect Dis. 2009;49(6):942–8. 10.1086/60549619663604 5FourieED, MorrisonJG. Rheumatoid arthritic syndrome after" exact="chikungunya" post="fever. S Afr Med J. 1979;56(4):130–2. 494034 6JavelleE, RiberaA,"/>
  <result pre="2006–2012.PLoS Negl Trop Dis.2015;9(3):e000360310.1371/journal.pntd.000360325760632 7SchwartzO, AlbertML. Biology and pathogenesis of" exact="chikungunya" post="virus. Nat Rev Microbiol. 2010;8(7):491–500. 10.1038/nrmicro236820551973 8Fernandez-SalasI, Danis-LozanoR, Casas-MartinezM,"/>
  <result pre="Aedes aegypti as a main contributor of fast dispersal of" exact="chikungunya" post="outbreaks in Latin America. Antiviral Res. 2015;124:30–42. 10.1016/j.antiviral.2015.10.01526518229 9ChenR,"/>
  <result pre="10.1128/JVI.01166-1627654297 10JohanssonMA, PowersAM, PesikN, CohenNJ, StaplesJE. Nowcasting the spread of" exact="chikungunya" post="virus in the Americas.PLoS One.2014;9(8):e10491510.1371/journal.pone.010491525111394 11AmraouiF, FaillouxAB. Chikungunya: an"/>
  <result pre="ZhangJ, LewisE, PlanchartA, LawsonTG. Degradation of the encephalomyocarditis virus and" exact="hepatitis" post="A virus 3C proteases by the ubiquitin/26S proteasome system"/>
  <result pre="Alphaviruses.Viruses. 2019;11(4). 34ThioCL, YusofR, Abdul-RahmanPS, KarsaniSA. Differential proteome analysis of" exact="chikungunya" post="virus infection on host cells.PLoS One. 2013;8(4):e6144410.1371/journal.pone.006144423593481 35AbrahamR, MudaliarP,"/>
  <result pre="Replicase. J Virol. 2018;92(14). 58KimDY, AtashevaS, FrolovaEI, FrolovI. Venezuelan equine" exact="encephalitis" post="virus nsP2 protein regulates packaging of the viral genome"/>
  <result pre="JagannathS, WenPY, BarlogieB, BerensonJ, et al.Frequency, characteristics, and reversibility of" exact="peripheral neuropathy" post="during treatment of advanced multiple myeloma with bortezomib.J Clin"/>
  <result pre="WenPY, BarlogieB, BerensonJ, et al.Frequency, characteristics, and reversibility of peripheral" exact="neuropathy" post="during treatment of advanced multiple myeloma with bortezomib.J Clin"/>
  <result pre="characteristics, and reversibility of peripheral neuropathy during treatment of advanced" exact="multiple myeloma" post="with bortezomib.J Clin Oncol. 2006;24(19):3113–20. 10.1200/JCO.2005.04.777916754936 63AleA, BrunaJ, NavarroX,"/>
  <result pre="2019;63(4). 69KaurP, ThiruchelvanM, LeeRC, ChenH, ChenKC, NgML, et al.Inhibition of" exact="chikungunya" post="virus replication by harringtonine, a novel antiviral that suppresses"/>
 </snippets>
</snippetsTree>
